linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Indostar Capital Finance Ltd.
 
Source DateBoard Meeting DateDetails
18 May 202627 May 2026 Audited Results
27 Jan 202609 Feb 2026 Quarterly Results (Revised)
20 Jan 202629 Jan 2026 Quarterly Results
23 Oct 202530 Oct 2025 Quarterly Results
07 Aug 202513 Aug 2025 Quarterly Results
23 Apr 202529 Apr 2025 Audited Results
13 Jan 202520 Jan 2025 Quarterly Results
10 Oct 202418 Oct 2024 Quarterly Results
26 Aug 202429 Aug 2024 Inter alia, to consider and approve:- i. issue of Non-Convertible Debentures for an amount not exceeding INR 6,000 crore on private placement basis, during a year from the date of the approval of the shareholders; ii. amendment to the Articles of Association of the Company, to incorporate specific clause relating to authorizing Debenture Trustees to appoint nominee director in terms of clause (e) of sub-regulation (1) of regulation 15 of the Securities and Exchange Board of India (Debenture Trustees) Regulations, 1993.
24 Jul 202431 Jul 2024 Quarterly Results
17 Apr 202429 Apr 2024Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 (Listing Regulations) Board Meeting 0.23 MB XBRLIndostar Capital Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 ,inter alia, to consider and approve we wish to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 29 April 2024, inter-alia the following matters: (i) Consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended 31 March 2024; (ii) Consider recommendation of dividend, if any, on equity shares of the Company, for the financial year ended 31st March 2024 for approval of the shareholders at the ensuing Annual General Meeting; (iii) Consider and approve issue of Non-Convertible Debentures for an amount not exceeding INR 6,000 crore in year through private placement.
22 Feb 202427 Feb 2024 Issue Of Warrants Inter alia, to consider and evaluate a proposal for raising of funds by way of issue of one or more instrument/securities including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue on a private placement basis, rights issue or any other methods or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required. The Board of Directors, if required, would also consider convening an extra-ordinary general meeting/ postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal, as required.
18 Jan 202424 Jan 2024 Quarterly Results Inter alia, to consider and approve the following:- On account of re-constitution of Borrowing/Debenture Committee of the Company, to approve and pass resolutions in supersession of the earlier resolutions passed pursuant to Borrowings of the Company
19 Oct 202327 Oct 2023 Quarterly Results
17 Aug 202321 Aug 2023 A.G.M.
26 Jul 202302 Aug 2023 Quarterly Results & Inter alia, to consider and approve:- (i) To consider and approve issue of Non-Convertible Debentures for an amount not exceeding INR 7,500 crore in year through private placement.
17 May 202325 May 2023 Audited Results
06 Feb 202314 Feb 2023 Quarterly Results
02 Nov 202208 Nov 2022 Quarterly Results
08 Aug 202214 Aug 2022 Quarterly Results Inter alia, to consider and approve:- (i) Issue of Non-Convertible Debentures ("NCD") on private placement basis, in one or more tranches from time to time, subject to the approval of shareholders of the Company; (ii) Convening 13th AGM to seek approval of shareholders inter-alia for issue of NCD for an amount not exceeding INR 3,000 crore on private placement basis, during a year from the date of the approval of the shareholders.
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.